Egbe Alexander C, Miranda William R, Ahmed Marwan, Karnakoti Snigdha, Kandlakunta Sriharsha, Eltony Muhammad, Meshreky Marianne, Burchill Luke J, Connolly Heidi M
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Int J Cardiol Congenit Heart Dis. 2024 Feb 15;15:100499. doi: 10.1016/j.ijcchd.2024.100499. eCollection 2024 Mar.
Aging is associated with acquired comorbidities that potentially influence the natural history and outcomes of adults with congenital heart disease (CHD). The purpose of this study was to compare the clinical characteristics, as well as the incidence and correlates of all-cause mortality between different age groups.
Adults with CHD were categorized into 3 age groups based on age at baseline encounter: Group 1 (age 18-40 years); Group 2 (age 41-65 years), and Group 3 (age >65 years).
Of 5930 patients (age 37 ± 15 years), 3009 (51%), 2422 (41%), and 499 (8%) were in Groups 1, 2 and 3, respectively. Compared to Group 1, patients in Groups 2 and 3 were less likely to have complex CHD, but more likely to have acquired comorbidities, end-organ dysfunction, ventricular systolic dysfunction, and valvular heart disease. Compared to Group 1, Groups 2 and 3 had higher incidence of all-cause mortality (7.2 versus 15.3 versus 47.8 per 1000 patient-years, respectively, p < 0.001), and lower proportion of deaths from cardiovascular causes (87% versus 77% versus 71%, respectively, p < 0.001). Furthermore, the correlates of all-cause mortality were different between the age groups, with acquired comorbidities such as hypertension, coronary artery disease, and hepatorenal dysfunction being associated with mortality in Group 3, while indices of CHD severity such as number of prior cardiac surgery, and presence of complex CHD being associated with all-cause mortality in Group 1.
These results suggest the need for management strategies tailored to address the correlates of outcomes in each age group.
衰老与后天合并症相关,而后天合并症可能会影响先天性心脏病(CHD)成人患者的自然病史和预后。本研究的目的是比较不同年龄组的临床特征以及全因死亡率的发生率和相关因素。
根据初次就诊时的年龄,将患有CHD的成人分为3个年龄组:第1组(18 - 40岁);第2组(41 - 65岁)和第3组(年龄>65岁)。
在5930例患者(年龄37±15岁)中,分别有3009例(51%)、2422例(41%)和499例(8%)属于第1组、第2组和第3组。与第1组相比,第2组和第3组患者患复杂CHD的可能性较小,但更有可能患有后天合并症、终末器官功能障碍、心室收缩功能障碍和心脏瓣膜病。与第1组相比,第2组和第3组的全因死亡率更高(分别为每1000患者年7.2例、15.3例和47.8例,p<0.001),且心血管原因导致的死亡比例更低(分别为87%、77%和71%,p<0.001)。此外,不同年龄组的全因死亡率相关因素有所不同,高血压、冠状动脉疾病和肝肾功 能障碍等后天合并症与第3组的死亡率相关,而既往心脏手术次数和复杂CHD的存在等CHD严重程度指标与第1组的全因死亡率相关。
这些结果表明需要制定针对性的管理策略,以应对各年龄组预后的相关因素。